Double Trouble: Tyco Gets Two FDA Warning Letters After Class I Recalls

Tyco Healthcare must resolve two separate warning letters from FDA after inspections of two of the firm's Mexican facilities last fall uncovered quality systems violations

More from Archive

More from Medtech Insight